Abstract
Please check if the section headings are assigned to appropriate levels.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.
Burlew BS, Weber KT. Cardiac fibrosis as a cause of diastolic dysfunction. Herz. 2002;27(2):92–8.
Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ, et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol. 2006;47(12):2357–63.
Verdecchia P, Reboldi G, Gattobigio R, Bentivoglio M, Borgioni C, Angeli F, et al. Atrial fibrillation in hypertension: predictors and outcome. Hypertension. 2003;41(2):218–23.
Losi MA, Izzo R, De Marco M, Canciello G, Rapacciuolo A, Trimarco V, et al. Cardiovascular ultrasound exploration contributes to predict incident atrial fibrillation in arterial hypertension: the Campania salute network. Int J Cardiol. 2015;199:290–5.
Nagarajarao HS, Penman AD, Taylor HA, Mosley TH, Butler K, Skelton TN, et al. The predictive value of left atrial size for incident ischemic stroke and all-cause mortality in African Americans: the atherosclerosis risk in communities (ARIC) study. Stroke. 2008;39(10):2701–6.
Gardin JM, McClelland R, Kitzman D, Lima JA, Bommer W, Klopfenstein HS, et al. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the cardiovascular health study). Am J Cardiol. 2001;87(9):1051–7.
Losi MA, Izzo R, Canciello G, Giamundo A, Manzi MV, Strisciuglio T, et al. Atrial dilatation development in hypertensive treated patients: the Campania-salute network. Am J Hypertens. 2016;29(9):1077–84.
Schneider MP, Hua TA, Böhm M, Wachtell K, Kjeldsen SE, Schmieder RE. Prevention of atrial fibrillation by renin-angiotensin system inhibition. J Am Coll Cardiol. 2010;55(21):2299–307.
Cappato R, Ezekowitz MD, Klein AL, Camm AJ, Ma CS, Le Heuzey JY, et al. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation. Eur Heart J. 2014;35(47):3346–55.
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–91.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Izzo, R. (2017). Patient with Hypertension and Left Atrial Enlargement. In: Hypertension and Cardiac Organ Damage. Practical Case Studies in Hypertension Management. Springer, Cham. https://doi.org/10.1007/978-3-319-56080-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-56080-9_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56079-3
Online ISBN: 978-3-319-56080-9
eBook Packages: MedicineMedicine (R0)